Table 2.
Antibiotic susceptibility profile
| ATB | E. coli | Klebsiella spp | Total | |||
|---|---|---|---|---|---|---|
| R (n/N) | R (%) | R (n/N) | R (%) | R (n/N) | R (%) | |
| TZP | 16/91 | 17.58 | 19/24 | 29.69 | 35/155 | 22.58 |
| FOX | 18/71 | 25.35 | 12/52 | 23.08 | 30/123 | 24.39 |
| CAZ | 89/91 | 97.80 | 63/64 | 98.44 | 152/155 | 98.06 |
| CRO | 91/91 | 100 | 63/64 | 98.44 | 154/155 | 99.35 |
| CTX | 91/91 | 100 | 62/64 | 96.88 | 153/155 | 98.71 |
| FEP | 89/91 | 97.80 | 64/64 | 100 | 153/155 | 98.71 |
| ATM | 90/91 | 98.90 | 63/64 | 98.44 | 153/155 | 98.71 |
| IMP | 2/91 | 2.20 | 1/64 | 1.56 | 3/155 | 1.94 |
| G | 69/91 | 75.82 | 51/64 | 79.69 | 120/155 | 77.42 |
| AKN | 3/91 | 3.30 | 1/64 | 1.56 | 4/155 | 2.58 |
| NA | 87/90 | 96.67 | 51/63 | 80.95 | 138/155 | 90.20 |
| CIP | 86/91 | 94.51 | 58/64 | 90.63 | 144/155 | 92.90 |
| FOS | 4/90 | 4.44 | 3/64 | 4.69 | 7/154 | 4.55 |
| SXT | 85/90 | 94.44 | 56/61 | 96.72 | 144/151 | 95.36 |
| DOX | 86/89 | 96.63 | 58/63 | 92.06 | 144/152 | 94.74 |
ATB antibiotic, R resistant, TZP piperacillin-tazobactam, FOX cefoxitin, CAZ ceftazidim, CRO ceftriaxon, CTX cefotaxim, FEP cefepim, ATM aztreonam, IPM imipenem, G gentamicin, AKN amikacin, NA nalidixic acid, CIP ciprofloxacin, FOS fosfomycin, SXT trimethoprim / sulfamethoxazole